TRANSLATION AND VALIDATION OF HINDI VERSION OF DIABETES QUALITY OF LIFE – MEASURE (DQOL-M) IN INDIAN TYPE 2 DIABETES PATIENTS
Author(s)
Pawar S*1, Thakurdesai P2 1Smt. Kashibai Navale College of Pharmacy, Pune and Research Scholar Karpagam University, Coimbatore, Pune, India, 2Indus Biotech Private Limited, Pune, India
Presentation Documents
OBJECTIVES: To test the reliability and validity and of newly translated Hindi version of DQOL-M instrument in Indian type 2 diabetic populations. METHODS: Backward and forward translation was carried out and intermediate version was compared with original instrument to check the linguistic equivalence. After pilot testing the final Hindi version of DQOL-M was administered to 250 patients with type 2 diabetes twice at the interval of four weeks. Psychometric parameters like treatment satisfaction, Impact of treatment, worries of social vocational issues of diabetes were assessed. Cronbach alpha for total score was calculated to study the reliability of instrument. RESULTS: Internal consistency was assessed using Cronbach alpha and value of 0.86 was gained for the summary score. Cronbach alpha for treatment satisfaction was found to be 0.77, for Impact of treatment it was 0.73 and for worries of social vocational issues score of 0.83 was gained. No significant difference was observed in test-retest analysis. Pearson correlations were assessed for all the four subscales and were found to be significant. CONCLUSIONS: This modified and final translated version of instrument confirms the linguistic validity of the questionnaire for the Hindi language and evaluates the psychometric properties of the questionnaire for psychometric validation. Indian Hindi version of DQOL-M is valid and reliable instrument for measuring HRQOL of diabetic type 2 patients.
Conference/Value in Health Info
2013-09, ISPOR Latin America 2013, Buenos Aires, Argentina
Value in Health, Vol. 16, No. 7 (November 2013)
Code
PDB22
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Diabetes/Endocrine/Metabolic Disorders